S&P 500
(-0.24%) 5 023.71 points
Dow Jones
(0.33%) 37 940 points
Nasdaq
(-0.33%) 15 606 points
Oil
(-3.20%) $79.31
Gas
(-2.71%) $1.937
Gold
(0.54%) $2 315.30
Silver
(0.39%) $26.76
Platinum
(1.22%) $959.75
USD/EUR
(-0.02%) $0.937
USD/NOK
(-0.08%) $11.09
USD/GBP
(0.12%) $0.801
USD/RUB
(-0.48%) $93.00

实时更新: Arch Therapeutics, Inc. [ARTH]

交易所: PNK 工业: Biotechnology
最后更新时间25 Apr 2024 @ 01:58

0.00% $ 1.180

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 01:58):

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease...

Stats
今日成交量 65.00
平均成交量 3 344.00
市值 5.60M
EPS $0 ( 2024-01-05 )
下一个收益日期 ( $0 ) 2024-05-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.840
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2023-08-31 Abrams Michael S Buy 20 584 Warrants (right to buy)
2023-08-31 Abrams Michael S Buy 10 292 Common Stock
2023-08-31 Norchi Terrence W Buy 13 724 Warrants (right to buy)
2023-08-31 Norchi Terrence W Buy 6 862 Common Stock
2023-08-31 Hicks Laurence Buy 20 584 Warrants (right to buy)
INSIDER POWER
100.00
Last 89 transactions
Buy: 27 633 666 | Sell: 2 335 000

Arch Therapeutics, Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Arch Therapeutics, Inc. 财务报表

Annual 2023
营收: $75 724.00
毛利润: $-2 439.00 (-3.22 %)
EPS: $-2.27
FY 2023
营收: $75 724.00
毛利润: $-2 439.00 (-3.22 %)
EPS: $-2.27
FY 2022
营收: $15 652.00
毛利润: $-35 837.00 (-228.96 %)
EPS: $-3.56
FY 2021
营收: $11 565.00
毛利润: $-14 717.00 (-127.25 %)
EPS: $-0.0300

Financial Reports:

No articles found.

Arch Therapeutics, Inc.

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。